Mannucci E, Ghetti G. Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 2022;23(1). https://doi.org/10.7175/fe.v23i1.1539